Announcements & Media Coverage

Hemogenyx Pharmaceuticals plc (“Hemogenyx Pharmaceuticals” or the “Company”)   Immuno-Oncology Summit Europe Presentation   Hemogenyx Pharmaceuticals plc (LSE: HEMO) is pleased to announce its participation in the Immuno-Oncology Summit Europe 2022, at which Dr Vladislav Sandler will make a presentation entitled “Anti-FLT3 CAR-T and Bispecific Antibody Therapies for Effective Elimination of AML and Conditioning for...